Claim CME & Certificate of Attendance
Statement of Need: Urology Practitioners must develop competence in implementation of the latest clinical practice guidelines and appropriate use of new and emerging surgical techniques to ensure the highest standards of patient care and safety.
Learning Objectives
After participation in this CME activity, participants will be able to:
-
Evaluate the current evidence surrounding regenerative therapies for sexual medicine conditions.
-
Describe basic details of atypical therapies for androgen supplementation, including with DHEA, DHT, SARMs, and other similar therapies.
-
Utilize management strategies for non-PD related penile pain.
-
Perform an adequate penile ultrasound using appropriate techniques.
-
Manage complex penile prosthesis scenarios using contemporary techniques.
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this (live) activity for a maximum of (TBD) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence-Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity are required to disclose to the AUA, as the ACCME-accredited provider, all financial relationships with any ineligible companies during the previous 24 months. The AUA must determine if the individual's relationships are relevant to the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners with information so they can make their own judgments. Disclosure reports will be posted to this page within a week of the activity start date.
Mitigation of Identified Conflict of Interest: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of relevant financial relationships. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation.
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
All relevant financial relationships will be posted here prior to the start if the meeting.
Attention: Restrictions on use of SMSNA content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
